Target intelligence / Profile preview

Low-Density Lipoprotein Receptor mRNA Degradation (LDLR mRNA Degradation)

Target
LDLR mRNA Degradation
Molecular classification
RNA degradation pathway, Post-transcriptional regulation
01

Overview

Low-density lipoprotein receptor (LDLR) mRNA degradation refers to the cellular processes that regulate the stability and turnover of LDLR messenger RNA, thereby controlling the amount of LDLR protein produced in cells. The LDLR is a key cell-surface receptor responsible for removing cholesterol-rich low-density lipoproteins (LDL) from circulation. Regulation at the mRNA level, particularly through RNA-binding proteins like hnRNPD, is crucial for maintaining cholesterol homeostasis. Targeting this pathway presents a potential therapeutic strategy for managing hypercholesterolemia.

Other names
LDLR mRNA TurnoverLDLR mRNA StabilityRegulation of LDLR mRNAhnRNPD-mediated LDLR mRNA decay
02

Mechanism of action

Berberine stabilizes LDLR mRNA by interfering with ARE-binding proteins’ interaction with the 3′ UTR, reducing hnRNPD levels.

03

Biological functions

Regulation of gene expressionControl of LDLR protein levelsCholesterol homeostasismRNA turnover
04

Disease associations

HypercholesterolemiaCardiovascular diseaseAtherosclerosis
05

Safety considerations

Off-target effects of drugs modulating RNA-binding proteins.Potential disruption of other mRNA targets regulated by the same RNA-binding proteins.
06

Interacting drugs

Berberine

Beyond the preview

Go deeper on Low-Density Lipoprotein Receptor mRNA Degradation (LDLR mRNA Degradation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Low-Density Lipoprotein Receptor mRNA Degradation (LDLR mRNA Degradation).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call